[ad_1]
Purity "France brush" On US Food and Drug Administration official Stephen Hahn saying that "Allowing these monoclonal antibody therapies could allow patients to avoid hospitalization and reduce the burden on our healthcare system.".
For his part, the CEO of the company said "Regeneron"Leonard Schleifer, this is framing "An important step in the fight against Covid-19, as high-risk patients in the United States will be able to receive promising treatment early in the course of the infection.".
“>
The head of the team responsible for the development of the Corona vaccine, Moncef Al-Salawi, told CNN: “Our plan is to be able to send vaccines to vaccination sites within 24 hours of the date of approval by the Administration of US Food and Drug
“Therefore, I hope this will be done on the second day of approval, that is, on December 11 or 12,” he added.
On Friday, the US company “Pfizer” and its German partner “Biontech” announced that they had submitted an application to the US Food and Drug Administration to approve the emergency use of the Covid-19 vaccine.
The companies expect the Food and Drug Administration to grant approval for emergency use in mid-December.
And they said they will begin shipping the doses immediately, knowing that Pfizer expects to have 50 million doses of vaccines ready this year, enough to protect 25 million people.
In the same context, the US Food and Drug Administration granted, on Saturday, emergency approval to use a treatment for Covid-19, which was developed by the biotech company “Regeneron.”
The approved drug was used to treat US President Donald Trump when he contracted Covid-19.
“France Press” quoted US Food and Drug Administration official Stephen Hahn as saying that “allowing these monoclonal antibody treatments can allow patients to avoid hospitalization and reduce the burden on our health care system.”
For his part, the CEO of “Regeneron”, Leonard Schleifer, said that this constitutes “an important step in the fight against Covid-19, since high-risk patients in the United States will be able to obtain promising treatment in the first stages of the course of infection “.
[ad_2]
